Vet Lines MSDS Nexgard Spectra SDS August 2015

SAFETY DATA SHEET Page 1 of 5 Reviewed on: 26 August 2015 Product Name: NEXGARD Spectra SECTION 1: IDENTIFICATION OF THE SUBSTANCE AND SUPPLIER Product name: NEXGARD Spectra Product code: A011184 Recommended use: For the treatment and prevention of ectoparasite infestations and worms in dogs. Company details: Merial New Zealand Limited Address: Level 3 - Merial Building Osterley Way Manukau City New Zealand Telephone number: Phone: +64 9 980 1600 Fax: +64 9 980 1601 Emergency telephone number: Merial Ancare Freephone: 0800 800 822 National Poisons Centre : 0800 764 766 (0800 POISON) Fire Service, Ambulance : Dial 111 Date of preparation: 26 August 2015 SECTION 2: COMPOSITION/INFORMATION ON INGREDIENTS Chemical characterization: Product components: Ingredients Afoxolaner Milbemycin Oxime Non-hazardous CAS No. 1093861-60-9 129496-10-2 - %W/W 1.9 0.4 97.7 SECTION 3: HAZARDS IDENTIFICATION Hazard classifications: 9.1A Priority and secondary identifiers: WARNING KEEP OUT OF REACH OF CHILDREN WARNING Dangerous to the environment Toxic to aquatic life Risk and safety phrases: 9.1A Very toxic to aquatic organisms. Avoid contamination of any water supply with product or empty container. SECTION 4: FIRST AID MEASURES Necessary first aid measures: Workplace facilities: Symptoms and effects Notes for medical personnel: For advice contact the National Poisons Centre on 0800 POISON (0800 764 766), or a doctor immediately. Ingestion: If swallowed, not anticipated to cause problems, however, if problems develop, seek immediate medical attention. Eyes: In case of contact or if eyes become irritated during administration, immediately flush eyes with plenty of water for at least 15 minutes. If ocular irritation persists, seek medical attention. Skin: In case of contact or if skin become irritated during administration, immediately wash skin with soap and water. Remove contaminated clothing and shoes and launder before reuse. If skin irritation develops and persists or recurs, seek medical attention. Inhalation: If lungs become irritated or breathing is difficult during administration, move to fresh air and seek medical attention. No special facilities required.